Aethlon Medical, Inc.
AEMD
$4.66
$0.4510.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.10% | -9.40% | -9.66% | 21.97% | 3.11% |
| Total Depreciation and Amortization | -2.62% | 33.93% | 33.34% | 36.26% | 43.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 414.31% | 359.15% | 316.69% | -57.71% | -5.99% |
| Change in Net Operating Assets | -249.79% | -210.67% | -80.45% | -174.75% | 455.83% |
| Cash from Operations | 20.76% | 18.97% | 24.52% | 18.77% | 11.69% |
| Capital Expenditure | 100.00% | 100.00% | 100.00% | 97.24% | 96.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | 100.00% | 97.24% | 96.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.58% | -55.04% | 498.25% | 327.01% | 417.50% |
| Repurchase of Common Stock | 26.67% | 39.05% | 45.69% | 23.18% | -12.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.80% | -58.08% | 500.14% | 335.52% | 426.15% |
| Foreign Exchange rate Adjustments | -454.93% | -3,033.33% | -710.00% | -611.76% | 197.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.01% | -38.46% | 100.77% | 66.97% | 64.82% |